CN Patent

CN113499343A — 局部组合物

Assigned to MC2 Therapeutics Ltd · Expires 2021-10-15 · 5y expired

What this patent protects

本发明涉及包含多微泡分散体的用于局部施用的组合物，所述多微泡分散体包含连续的水相和至少一种不连续的油相，其中，所述多微泡分散体包含卡泊三醇、倍他米松二丙酸酯，α‑生育酚和丁基羟基茴香醚，并且其中，所述组合物的pH为7.75±0.5。

USPTO Abstract

本发明涉及包含多微泡分散体的用于局部施用的组合物，所述多微泡分散体包含连续的水相和至少一种不连续的油相，其中，所述多微泡分散体包含卡泊三醇、倍他米松二丙酸酯，α‑生育酚和丁基羟基茴香醚，并且其中，所述组合物的pH为7.75±0.5。

Drugs covered by this patent

Diprolene (BETAMETHASONE DIPROPIONATE) · Merck & Co.

Patent Metadata

Patent number: CN113499343A
Jurisdiction: CN
Classification: —
Expires: 2021-10-15
Drug substance claim: No
Drug product claim: No
Assignee: MC2 Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.